0001214659-19-000457.txt : 20190122 0001214659-19-000457.hdr.sgml : 20190122 20190122190033 ACCESSION NUMBER: 0001214659-19-000457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190117 FILED AS OF DATE: 20190122 DATE AS OF CHANGE: 20190122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 19536300 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-43763.xml PRIMARY DOCUMENT X0306 4 2019-01-17 0001576263 Mirati Therapeutics, Inc. MRTX 0001197355 FUCHS HENRY J C/O MIRATI THERAPEUTICS INC. 9393 TOWN CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 true false false false Non-Qualified Stock Option (right to buy) 64.14 2019-01-17 4 A false 11000 0 A 2029-01-16 Common Stock 11000 11000 D The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant. /s/ Vickie Reed, Attorney-in-Fact 2019-01-22